{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:31:42Z","timestamp":1777498302937,"version":"3.51.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T00:00:00Z","timestamp":1548028800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12929-019-0503-3","type":"journal-article","created":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T09:03:30Z","timestamp":1548061410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Brazilian strains of Toxoplasma gondii are controlled by azithromycin and modulate cytokine production in human placental explants"],"prefix":"10.1186","volume":"26","author":[{"given":"Priscila Silva","family":"Franco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula Suellen Guimar\u00e3es","family":"Gois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Th\u00e1dia Evelyn","family":"de Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafaela Jos\u00e9","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bellisa","family":"de Freitas Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelica","family":"de Oliveira Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Ietta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara Affonso","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria C\u00e9lia","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Roberto","family":"Mineo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7447-2583","authenticated-orcid":false,"given":"Eloisa Am\u00e1lia Vieira","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,21]]},"reference":[{"key":"503_CR1","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1891\/0730-0832.34.5.274","volume":"34","author":"MM Hampton","year":"2015","unstructured":"Hampton MM. Congenital toxoplasmosis: a review. Neonatal Netw. 2015;34:274\u20138.","journal-title":"Neonatal Netw"},{"key":"503_CR2","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","volume":"363","author":"JG Montoya","year":"2004","unstructured":"Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363:1965\u201376.","journal-title":"Lancet"},{"key":"503_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.pt.2005.11.001","volume":"22","author":"S Sonda","year":"2006","unstructured":"Sonda S, Hehl AB. Lipid biology of Apicomplexa: perspectives for new drug targets, particularly for Toxoplasma gondii. Trends Parasitol. 2006;22:41\u20137.","journal-title":"Trends Parasitol"},{"key":"503_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.actatropica.2011.10.018","volume":"121","author":"Y Carlier","year":"2012","unstructured":"Carlier Y, Truyens C, Deloron P, Peyron F. Congenital parasitic infections: a review. Acta Trop. 2012;121:55\u201370.","journal-title":"Acta Trop"},{"key":"503_CR5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1017\/S1466252315000183","volume":"16","author":"HM Wyrosdick","year":"2015","unstructured":"Wyrosdick HM, Schaefer JJ. Toxoplasma gondii: history and diagnostic test development. Anim Health Res Rev. 2015;16:150\u201362.","journal-title":"Anim Health Res Rev"},{"key":"503_CR6","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1128\/CMR.05013-11","volume":"25","author":"F Robert-Gangneux","year":"2012","unstructured":"Robert-Gangneux F, Darde ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012;25:264\u201396.","journal-title":"Clin Microbiol Rev"},{"key":"503_CR7","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/infdis\/172.6.1561","volume":"172","author":"DK Howe","year":"1995","unstructured":"Howe DK, Sibley LD. Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis. 1995;172:1561\u20136.","journal-title":"J Infect Dis"},{"key":"503_CR8","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ijpara.2007.09.004","volume":"38","author":"HF Pena","year":"2008","unstructured":"Pena HF, Gennari SM, Dubey JP, Su C. Population structure and mouse-virulence of Toxoplasma gondii in Brazil. Int J Parasitol. 2008;38:561\u20139.","journal-title":"Int J Parasitol"},{"key":"503_CR9","doi-asserted-by":"publisher","first-page":"e1000404","DOI":"10.1371\/journal.pgen.1000404","volume":"5","author":"A Khan","year":"2009","unstructured":"Khan A, Taylor S, Ajioka JW, Rosenthal BM, Sibley LD. Selection at a single locus leads to widespread expansion of Toxoplasma gondii lineages that are virulent in mice. PLoS Genet. 2009;5:e1000404.","journal-title":"PLoS Genet"},{"key":"503_CR10","doi-asserted-by":"publisher","first-page":"5844","DOI":"10.1073\/pnas.1203190109","volume":"109","author":"C Su","year":"2012","unstructured":"Su C, Khan A, Zhou P, Majumdar D, Ajzenberg D, Dard\u00e9 ML, Zhu XQ, Ajioka JW, Rosenthal BM, Dubey JP, Sibley LD. Globally diverse Toxoplasma gondii isolates comprise six major clades originating from a small number of distinct ancestral lineages. Proc Natl Acad Sci U S A. 2012;109:5844\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"503_CR11","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1017\/S0031182013001844","volume":"141","author":"EK Shwab","year":"2014","unstructured":"Shwab EK, Zhu XQ, Majumdar D, Pena HF, Gennari SM, Dubey JP, Su C. Geographical patterns of Toxoplasma gondii genetic diversity revealed by multilocus PCR-RFLP genotyping. Parasitology. 2014;141:453\u201361.","journal-title":"Parasitology"},{"key":"503_CR12","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1017\/S0031182012000765","volume":"139","author":"JP Dubey","year":"2012","unstructured":"Dubey JP, Lago EG, Gennari SM, Su C, Jones JL. Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology. Parasitology. 2012;139:1375\u2013424.","journal-title":"Parasitology"},{"key":"503_CR13","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1017\/S0950268815003295","volume":"144","author":"CS Lopes","year":"2016","unstructured":"Lopes CS, Franco OS, Silva NM, Silva DAO, Ferro EAV, Pena HFJ, Soares RM, Gennari SM, Mineo JR. Phenotypic and genotypic characterization of two Toxoplasma gondii isolates in free-range chickens from Uberl\u00e2ndia, Brazil. Epidemiol Infect. 2016;144:1865\u201375.","journal-title":"Epidemiol Infect"},{"key":"503_CR14","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s10096-016-2656-2","volume":"35","author":"CP Rico-Torres","year":"2016","unstructured":"Rico-Torres CP, Vargas-Villavicencio J\u00c1, Correa D. Is Toxoplasma gondii type related to clinical outcome in human congenital infection? Systematic and critical review. Eur J Clin Microbiol Infect Dis. 2016;35:1079\u201388.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"503_CR15","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1051\/parasite\/2008153366","volume":"15","author":"ML Darde","year":"2008","unstructured":"Darde ML. Toxoplasma gondii, \u201cnew\u201d genotypes and virulence. Parasite. 2008;15:366\u201371.","journal-title":"Parasite"},{"key":"503_CR16","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1017\/S0031182011001478","volume":"138","author":"DS Lindsay","year":"2011","unstructured":"Lindsay DS, Dubey JP. Toxoplasma gondii: the changing paradigm of congenital toxoplasmosis. Parasitology. 2011;138:1829\u201331.","journal-title":"Parasitology"},{"key":"503_CR17","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s10096-013-2017-3","volume":"33","author":"W Wujcicka","year":"2014","unstructured":"Wujcicka W, Wilczy\u0144ski J, Nowakowska D. Do the placental barrier, parasite genotype and toll-like receptor polymorphisms contribute to the course of primary infection with various Toxoplasma gondii genotypes in pregnant women? Eur J Clin Microbiol Infect Dis. 2014;33:703\u20139.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"503_CR18","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1007\/s00436-014-3920-y","volume":"113","author":"PS Franco","year":"2014","unstructured":"Franco PS, Ribeiro M, Lopes-Maria JB, Costa LF, Silva DA, de Freitas Barbosa B, de Oliveira Gomes A, Mineo JR, Ferro EA. Experimental infection of Calomys callosus with atypical strains of Toxoplasma gondii shows gender differences in severity of infection. Parasitol Res. 2014;113:2655\u201364.","journal-title":"Parasitol Res"},{"key":"503_CR19","first-page":"181","volume":"10","author":"PS Franco","year":"2015","unstructured":"Franco PS, da Silva NM, de Freitas Barbosa B, de Oliveira Gomes A, Ietta F, Shwab EK, Su C, Mineo JR, Ferro EA. Calomys callosus chronically infected by Toxoplasma gondii clonal type II strain and reinfected by Brazilian strains is not able to prevent vertical transmission. Front Microbiol. 2015;10:181.","journal-title":"Front Microbiol"},{"key":"503_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.puhe.2007.08.009","volume":"122","author":"HM Elsheikha","year":"2008","unstructured":"Elsheikha HM. Congenital toxoplasmosis: priorities for further health promotion action. Public Health. 2008;122:335\u201353.","journal-title":"Public Health"},{"key":"503_CR21","volume-title":"Neonatology: management, procedures, on-call problems, diseases, and drugs -toxoplasmosis","author":"T Gomella","year":"2013","unstructured":"Gomella T, Cunningham MD, Eyal FG. Neonatology: management, procedures, on-call problems, diseases, and drugs -toxoplasmosis. 7th ed. New York: NY; 2013.","edition":"7"},{"key":"503_CR22","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1086\/590149","volume":"47","author":"JG Montoya","year":"2008","unstructured":"Montoya JG, Remington JS. Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis. 2008;47:554\u201366.","journal-title":"Clin Infect Dis"},{"key":"503_CR23","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.pedhc.2010.04.008","volume":"25","author":"A Kaye","year":"2011","unstructured":"Kaye A. Toxoplasmosis: diagnosis, treatment, and prevention in congenitally exposed infants. J Pediatr Health Care. 2011;25:355\u201364.","journal-title":"J Pediatr Health Care"},{"key":"503_CR24","doi-asserted-by":"publisher","first-page":"884e90","DOI":"10.1016\/j.placenta.2009.08.002","volume":"30","author":"IN Costa","year":"2009","unstructured":"Costa IN, Angeloni MB, Santana LA, Barbosa BF, Silva MCP, Rodrigues AA, Rostkowsa C, Magalh\u00e3es PM, Pena JD, Silva DA, Mineo JR, Ferro EA. Azithromycin inhibits vertical transmission of Toxoplasma gondii in Calomys callosus (Rodentia: Cricetidae). Placenta. 2009;30:884e90.","journal-title":"Placenta"},{"key":"503_CR25","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.placenta.2011.08.012","volume":"32","author":"PS Franco","year":"2011","unstructured":"Franco PS, Gomes AO, Barbosa BF, Angeloni MB, Silva NM, Teixeira-Carvalho A, Martins-Filho OA, Silva DA, Mineo JR, Ferro EA. Azithromycin and spiramycin induce anti-inflammatory response in human trophoblastic (BeWo) cells infected by Toxoplasma gondii but are able to control infection. Placenta. 2011;32:838\u201344.","journal-title":"Placenta"},{"key":"503_CR26","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/j.1447-0756.2010.01459.x","volume":"37","author":"S Tamaru","year":"2011","unstructured":"Tamaru S, Kikuchi A, Takagi K, Wakamatsu M, Horikoshi T, Ogiso Y. Fetal, therapy of severe symptomatic toxoplasmosis using azithromycin. J Obstet Gynaecol Res. 2011;37:953\u20137.","journal-title":"J Obstet Gynaecol Res"},{"key":"503_CR27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1479-5876-12-132","volume":"12","author":"LS Castro-Filice","year":"2014","unstructured":"Castro-Filice LS, Barbosa BF, Angeloni MB, Silva NM, Gomes AO, Alves CM, Silva DA, Martins-Filho OA, Santos MC, Mineo JR, Ferro EA. Azithromycin is able to control Toxoplasma gondii infection in human villous explants. J Transl Med. 2014;12:132.","journal-title":"J Transl Med"},{"key":"503_CR28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ijantimicag.2007.04.015","volume":"30","author":"E Pitsouni","year":"2007","unstructured":"Pitsouni E, Iavazzo C, Athanasiou S, Falagas ME. Single-dose azithromycin, versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials. Int J Antimicrob Agents. 2007;30:213\u201321.","journal-title":"Int J Antimicrob Agents"},{"key":"503_CR29","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1089\/dna.2011.1333","volume":"31","author":"P Srivastava","year":"2012","unstructured":"Srivastava P, Bhengraj AR, Jha HC, Vardhan H, Jha R, Singh LC, Salhan S, Mittal A. Differing effects of azithromycin and doxycycline on cytokines in cells from Chlamydia trachomatis-infected women. DNA Cell Biol. 2012;31:392\u2013401.","journal-title":"DNA Cell Biol"},{"key":"503_CR30","first-page":"5","volume":"117","author":"J Tamaoki","year":"2004","unstructured":"Tamaoki J, Kadota J, Takizawa H. Clinical implications of the immunomodulatory effects of macrolides. Am J Med. 2004;117:5\u201311.","journal-title":"Am J Med"},{"key":"503_CR31","first-page":"2","volume":"117","author":"BK Rubin","year":"2004","unstructured":"Rubin BK. Immunomodulatory properties of macrolides: overview and historical perspective. Am J Med. 2004;117:2\u20134.","journal-title":"Am J Med"},{"key":"503_CR32","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1128\/CMR.00078-09","volume":"23","author":"S Kanoh","year":"2010","unstructured":"Kanoh S, Rubin BK. Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev. 2010;23:590\u2013615.","journal-title":"Clin Microbiol Rev"},{"key":"503_CR33","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1210\/endo.138.9.5403","volume":"138","author":"I Caniggia","year":"1997","unstructured":"Caniggia I, Lye SJ, Cross JC. Activin is a local regulator of human cytotrophoblast cell differentiation. Endocrinol. 1997;138:3976\u201386.","journal-title":"Endocrinol"},{"key":"503_CR34","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1016\/j.ajpath.2011.02.005","volume":"178","author":"AO Gomes","year":"2011","unstructured":"Gomes AO, Silva DAO, Silva NM, Barbosa BF, Franco PS, Angeloni MB, Fermino ML, Roque-Barreira MC, Bechi N, Paulesu LR, Dos Santos MC, Mineo JR, Ferro EA. Effect of macrophage migration inhibitory factor (MIF) in human placental explants infected with Toxoplasma gondii depends on gestational age. Am J Pathol. 2011;178:2792\u2013801.","journal-title":"Am J Pathol"},{"key":"503_CR35","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1128\/JCM.01113-09","volume":"48","author":"T Wahab","year":"2010","unstructured":"Wahab T, Edvinsson B, Palm D, Lindh J. Comparison of the AF146527 and B1 repeated elements, two real-time PCR targets used for detection of Toxoplasma gondii. J Clin Microbiol. 2010;48:591\u20132.","journal-title":"J Clin Microbiol"},{"key":"503_CR36","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.ijpara.2006.03.003","volume":"36","author":"C Su","year":"2006","unstructured":"Su C, Zhang X, Dubey JP. Genotyping of Toxoplasma gondii by multilocus PCR-RFLP markers: a high resolution and simple method for identification of parasites. Int J Parasitol. 2006;36:841\u20138.","journal-title":"Int J Parasitol"},{"key":"503_CR37","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3201\/eid1504.081306","volume":"15","author":"B Carme","year":"2009","unstructured":"Carme B, Demar M, Ajzenberg D, Darde ML. Severe acquired toxoplasmosis caused by wild cycle of Toxoplasma gondii, French Guiana. Emerg Infect Dis. 2009;15:656\u20138.","journal-title":"Emerg Infect Dis"},{"key":"503_CR38","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1371\/journal.pntd.0000277","volume":"2","author":"RE Gilbert","year":"2008","unstructured":"Gilbert RE, Freeman K, Lago EG, Bahia-Oliveira LM, Tan HK, Wallon M, Buffolano W, Stanford MR, Petersen E. European multicentre study on congenital toxoplasmosis (EMSCOT). Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis. 2008;2:e277.","journal-title":"PLoS Negl Trop Dis"},{"key":"503_CR39","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1128\/JCM.02502-12","volume":"51","author":"AC Carneiro","year":"2013","unstructured":"Carneiro AC, Andrade GM, Costa JG, Pinheiro BV, Vasconcelos-Santos DV, Ferreira AM, Su C, Janu\u00e1rio JN, Vitor RW. Genetic characterization of Toxoplasma gondii revealed highly diverse genotypes for isolates from newborns with congenital toxoplasmosis in southeastern Brazil. J Clin Microbiol. 2013;51:901\u20137.","journal-title":"J Clin Microbiol"},{"key":"503_CR40","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1590\/S0074-02762009000200026","volume":"104","author":"R Gilbert","year":"2009","unstructured":"Gilbert R. Treatment for congenital toxoplasmosis: finding out what works. Mem Inst Oswaldo Cruz. 2009;104:305\u201311.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"503_CR41","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.exppara.2017.08.004","volume":"181","author":"M Ribeiro","year":"2017","unstructured":"Ribeiro M, Franco PS, Lopes-Maria JB, Angeloni MB, Barbosa BF, Gomes AO, Castro AS, Silva RJD, Oliveira FC, Milian ICB, Martins-Filho OA, Ietta F, Mineo JR, Ferro EAV. Azithromycin treatment is able to control the infection by two genotypes of Toxoplasma gondii in human trophoblast BeWo cells. Exp Parasitol. 2017;181:111\u20138.","journal-title":"Exp Parasitol"},{"key":"503_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0031182009991065","volume":"137","author":"C Su","year":"2010","unstructured":"Su C, Shwab EK, Zhou P, Zhu XQ, Dubey JP. Moving towards an integrated approach to molecular detection and identification of Toxoplasma gondii. Parasitology. 2010;137:1\u201311.","journal-title":"Parasitology"},{"key":"503_CR43","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0140-6736(07)60072-5","volume":"369","author":"R Thiebaut","year":"2007","unstructured":"Thiebaut R, Leprout S, Chene G, Gilbert R. Effectiveness of prenatal treatment for congenital toxoplasmosis: ameta-analysis of individual patients\u2019data. Lancet. 2007;369:115\u201322.","journal-title":"Lancet"},{"key":"503_CR44","doi-asserted-by":"publisher","first-page":"e1000351","DOI":"10.1371\/journal.pmed.1000351","volume":"7","author":"M Cortina-Borja","year":"2010","unstructured":"Cortina-Borja M, Tan HK, Wallon M, Paul M, Prusa A, Buffolano W, Malm G, Salt A, Freeman K, Petersen E, Gilbert RE, European multicentre study on congenital toxoplasmosis (EMSCOT). Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observation prospective cohort study. PLoS Med. 2010;7:e1000351.","journal-title":"PLoS Med"},{"key":"503_CR45","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1046\/j.1471-0528.2003.02325.x","volume":"110","author":"R Gilbert","year":"2003","unstructured":"Gilbert R, Gras L. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJO. 2003;110:112\u201320.","journal-title":"BJO"},{"key":"503_CR46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1128\/AAC.38.1.31","volume":"38","author":"ER Pfefferkorn","year":"1994","unstructured":"Pfefferkorn ER, Borotz SE. Comparison of mutants of Toxoplasma-Gondii selected for resistance to azithromycin, spiramycin, or clindamycin. Antimicrob Agents Chemother. 1994;38:31\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"503_CR47","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/37132","volume":"390","author":"ME Fichera","year":"1997","unstructured":"Fichera ME, Roos DS. A plastid organelle as a drug target in apicomplexan parasites. Nature. 1997;390:407\u20139.","journal-title":"Nature"},{"key":"503_CR48","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.4049\/jimmunol.167.8.4574","volume":"167","author":"DG Mordue","year":"2001","unstructured":"Mordue DG, Monroy F, La Regina M, Dinarello CA, Sibley LD. Acute toxoplasmosis leads to lethal over-production of Th1 cytokines. J Immunol. 2001;167:4574\u201384.","journal-title":"J Immunol"},{"key":"503_CR49","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1099\/jmm.0.04860-0","volume":"52","author":"TD Nguyen","year":"2003","unstructured":"Nguyen TD, Bigaignon G, Markine-Goriaynoff D, Heremans H, Nguyen TN, Warnier G, Delmee M, Warny M, Wolf SF, Uyttenhove C, Van Snick J, Coutelier JP. Virulent Toxoplasma gondii strain RH promotes T-cell-independent overproduction of proinflammatory cytokines IL12 and gamma-interferon. J Med Microbiol. 2003;52:869\u201376.","journal-title":"J Med Microbiol"},{"key":"503_CR50","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.pt.2005.08.001","volume":"21","author":"JPJ Saeij","year":"2005","unstructured":"Saeij JPJ, Boyle JP, Boothroyd JC. Differences among the three major strains of Toxoplasma gondii and their specific interactions with the infected host. Trends Parasitol. 2005;21:476\u201381.","journal-title":"Trends Parasitol"},{"key":"503_CR51","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nature05395","volume":"445","author":"JP Saeij","year":"2007","unstructured":"Saeij JP, Coller S, Boyle JP, Jerome ME, White MW, Boothroyd JC. Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Nature. 2007;445:324\u20137.","journal-title":"Nature"},{"key":"503_CR52","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.exppara.2011.08.016","volume":"129","author":"KC Glaser","year":"2011","unstructured":"Glaser KC, Hagos B, Molestina RE. Effects of Toxoplasma gondii genotype and absence of host MAL\/Myd88 on the temporal regulation of gene expression in infected microglial cells. Exp Parasitol. 2011;129:409\u201313.","journal-title":"Exp Parasitol"},{"key":"503_CR53","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1084\/jem.20100717","volume":"208","author":"EE Rosowski","year":"2011","unstructured":"Rosowski EE, Lu D, Julien L, Rodda L, Gaiser RA, Jensen KD, Saeij JP. Strain-specific activation of the NF-kappaB pathway by GRA15, a novel Toxoplasma gondii dense granule protein. J Exp Med. 2011;208:195\u2013212.","journal-title":"J Exp Med"},{"key":"503_CR54","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1128\/IAI.00947-10","volume":"79","author":"J Xiao","year":"2011","unstructured":"Xiao J, Jones-Brando L, Talbot CC Jr, Yolken RH. Differential effects of three canonical Toxoplasma strains on gene expression in human neuroepithelial cells. Infect Immun. 2011;79:1363\u201373.","journal-title":"Infect Immun"},{"key":"503_CR55","doi-asserted-by":"publisher","first-page":"678","DOI":"10.4161\/viru.22833","volume":"3","author":"A Sanecka","year":"2012","unstructured":"Sanecka A, Frickel EM. Use and abuse of dendritic cells by Toxoplasma gondii. Virulence. 2012;3:678\u201389.","journal-title":"Virulence"},{"key":"503_CR56","first-page":"791","volume":"3","author":"T Calandra","year":"2003","unstructured":"Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nature. 2003;3:791\u20138.","journal-title":"Nature"},{"key":"503_CR57","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1073\/pnas.1301128110","volume":"110","author":"R Das","year":"2013","unstructured":"Das R, Koo SM, Kim HB, Jacob TS, Subbian S, Yao J. Macrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosis. Proc Natl Acad Sci. 2013;110:2997\u20133006.","journal-title":"Proc Natl Acad Sci"},{"key":"503_CR58","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.4049\/jimmunol.161.5.2383","volume":"161","author":"S J\u00fcttner","year":"1998","unstructured":"J\u00fcttner S, Bernhagen J, Metz NC, Rollinghoff M, Bucala R, Gessner A. Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha. J Immunol. 1998;161:2383\u201390.","journal-title":"J Immunol"},{"key":"503_CR59","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2353\/ajpath.2008.070432","volume":"172","author":"EAV Ferro","year":"2008","unstructured":"Ferro EAV, Mineo JR, Ietta F, Bechi N, Romagnoli R, Silva DAO. Macrophage migration inhibitory factor is up-regulated in human first- trimester placenta stimulated by soluble antigen of Toxoplasma gondii, resulting in increased monocyte adhesion on villous explants. Am J Pathol. 2008;172:8\u201350.","journal-title":"Am J Pathol"},{"key":"503_CR60","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.placenta.2013.12.013","volume":"35","author":"BF Barbosa","year":"2014","unstructured":"Barbosa BF, Paulesu L, Ietta F, Bechi N, Rogmanoli R, Gomes AO, Favoreto-Junior S, Silva DAO, Mineo JR, Mineo TWP, Ferro EAV. Susceptibility to Toxoplasma gondii proliferation in BeWo human trophoblast cells is dose-dependent of macrophage migration inhibitory factor (MIF), via ERK1\/2 phosphorylation and prostaglandin E2 production. Placenta. 2014;35:152\u201362.","journal-title":"Placenta"},{"key":"503_CR61","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1600-0897.2009.00778.x","volume":"63","author":"V Dubinsky","year":"2010","unstructured":"Dubinsky V, Poehlmann TG, Suman P, Gentile T, Markert UR, Gutierrez G. Role of regulatory and angiogenic cytokines in invasion of trophoblastic cells. Am J Reprod Immunol. 2010;63:193\u20139.","journal-title":"Am J Reprod Immunol"},{"key":"503_CR62","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/molehr\/gas010","volume":"18","author":"H Champion","year":"2012","unstructured":"Champion H, Innes BA, Robson SC, Lash GE, Bulmer JN. Effects of interleukin-6 on extravillous trophoblast invasion in early human pregnancy. Mol Hum Reprod. 2012;18:391\u2013400.","journal-title":"Mol Hum Reprod"},{"key":"503_CR63","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1046\/j.1365-3024.1998.00152.x","volume":"20","author":"H Jebbari","year":"1998","unstructured":"Jebbari H, Roberts CW, Ferguson DJ, Bluethmann H, Alexander J. A protective role for IL-6 during early infection with Toxoplasma gondii. Parasite Immunol. 1998;20:231\u20139.","journal-title":"Parasite Immunol"},{"key":"503_CR64","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ajpath.2012.03.029","volume":"181","author":"U Handel","year":"2012","unstructured":"Handel U, Brunn A, Drogemuller K, Muller W, Deckert M, Schluter D. Neuronal gp130 expression is crucial to prevent neuronal loss, hyperinflammation, and lethal course of murine Toxoplasma encephalitis. Am J Pathol. 2012;181:163\u201373.","journal-title":"Am J Pathol"},{"key":"503_CR65","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1086\/322800","volume":"184","author":"ME Grigg","year":"2001","unstructured":"Grigg ME, Ganatra J, Boothroyd JC, Margolis TP. Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J Infect Dis. 2001;184:633\u20139.","journal-title":"J Infect Dis"},{"key":"503_CR66","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.placenta.2009.07.002","volume":"30","author":"MB Angeloni","year":"2009","unstructured":"Angeloni MB, Silva NM, Castro AS, Gomes AO, Silva DA, Mineo JR, Ferro EA. Apoptosis and S phase of the cell cycle in BeWo trophoblastic and HeLa cells are differentially modulated by Toxoplasma gondii strain types. Placenta. 2009;30:785\u201391.","journal-title":"Placenta"},{"key":"503_CR67","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.placenta.2013.09.005","volume":"34","author":"MB Angeloni","year":"2013","unstructured":"Angeloni MB, Guirelli PM, Franco PS, Barbosa BF, Gomes AO, Castro AS, Silva NM, Martins-Filho OA, Mineo TW, Silva DA, Mineo JR, Ferro EA. Differential apoptosis in BeWo cells after infection with highly (RH) or moderately (ME49) virulent strains of Toxoplasma gondii is related to the cytokine profile secreted, the death receptor Fas expression and phosphorylated ERK1\/2 expression. Placenta. 2013;34:973\u201382.","journal-title":"Placenta"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-019-0503-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12929-019-0503-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-019-0503-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T02:19:09Z","timestamp":1694571549000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-019-0503-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,21]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["503"],"URL":"https:\/\/doi.org\/10.1186\/s12929-019-0503-3","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,21]]},"assertion":[{"value":"21 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The institutional ethics committee approved the study (Approval Number: 1.155.475). Informed consent was obtained from six pregnant women participants included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"10"}}